2.8
Sell
Average of 2 AIs
↑ Improved from previous
Last Updated: 6 Mar 2026, 09:00 am IST | Report Date: Feb 15, 2026

Take Solutions Limited Stock Analysis

TAKE NSE 🇮🇳 India
3.5
ChatGPT
Sell
2.0
Claude
Strong Sell

Take Solutions Limited (TAKE) is a India-based company listed on NSE. This AI-powered analysis provides investment insights based on quarterly earnings reports and financial performance metrics.

Share Share Share

Overall verdict for a 6-12 month horizon is Sell, because reported profitability appears non-core and is overshadowed by serious balance-sheet and going-concern risks. In Q3 FY2025-26, PAT was Rs. 110.96 lakhs on total income of Rs. 146.14 lakhs, but this income was reported as entirely other income in management commentary, indicating weak earnings quality despite EPS of Rs. 0.08. Cost control was visible with total expenses at Rs. 35.18 lakhs (employee cost Rs. 13.53 lakhs, finance cost Rs. 0.06 lakhs), yet auditors maintained a qualified opinion and highlighted material uncertainties. The risk stack remains heavy: prior-year loss of Rs. 6,973.6 lakhs, direct tax litigations of Rs. 1,080.3 lakhs, and questionable recoverability of deferred tax assets (Rs. 883.2 lakhs) and indirect tax credits (Rs. 516.4 lakhs), along with unpaid statutory dues.

Based on: Take Solutions Limited - Financial Results (15/2/2026) (Feb 15, 2026)

AI Investment Score & Analysis

+ Key Strengths

Q3 FY2025-26 reported profit after tax of Rs. 110.96 lakhs and profit before tax of Rs. 110.96 lakhs, reversing from a Rs. 62.78 lakhs loss in the preceding quarter (as per quarterly narrative).
Total expenses were contained at Rs. 35.18 lakhs versus total income of Rs. 146.14 lakhs, indicating a lean current cost structure.
Finance costs were negligible at Rs. 0.06 lakhs, reducing near-term interest burden on the P&L.
Basic and diluted EPS were positive at Rs. 0.08 in Q3 FY2025-26.
The company completed a strategic action in FY2024-25 by divesting 100% of Ecron Acunova Limited, which provides optionality to reposition the business model.

- Key Risks

Auditor opinion is Qualified with explicit going-concern uncertainty, citing severe operational and financial stress factors.
Earnings quality is weak: management commentary says total income of Rs. 146.14 lakhs came entirely from other income, while operations were described as having no operational revenue.
Historical financial damage is significant, with FY2024-25 loss of Rs. 6,973.6 lakhs and substantial net worth erosion noted in risk disclosures.
Tax and compliance overhang is high, including direct tax litigations of Rs. 1,080.3 lakhs and unpaid statutory obligations.
Asset recoverability risk is elevated with deferred tax assets of Rs. 883.2 lakhs and indirect tax credits of Rs. 516.4 lakhs flagged as questionable, while cash-flow and liquidity metrics are largely unavailable in the extract.

Forward Outlook

This quarter’s key strategic context is post-divestment repositioning: after exiting Ecron Acunova, management is pursuing diversification outside CRO due to non-compete constraints. The stated forward plan is to close strategic partnerships, mergers, and acquisitions through non-cash transactions in FY2026, but management itself indicates outcomes and financial impact are still uncertain. For the next 2-4 quarters, the main catalysts are concrete closure and execution of these diversification deals rather than organic operating momentum. Current momentum appears decelerated in core operations because business commentary highlights severely impacted operations and no dependable operating revenue base. Until new initiatives convert into recurring revenue and governance overhangs reduce, near-term performance is likely to remain volatile and event-driven.

Detailed AI Analysis by Provider

3.5
OpenAI ChatGPT Sell
codex-cli (OpenAI Codex)

Overall verdict for a 6-12 month horizon is Sell, because reported profitability appears non-core and is overshadowed by serious balance-sheet and going-concern risks. In Q3 FY2025-26, PAT was Rs. 110.96 lakhs on total income of Rs. 146.14 lakhs, but this income was reported as entirely other income in management commentary, indicating weak earnings quality despite EPS of Rs. 0.08. Cost control was visible with total expenses at Rs. 35.18 lakhs (employee cost Rs. 13.53 lakhs, finance cost Rs. 0.06 lakhs), yet auditors maintained a qualified opinion and highlighted material uncertainties. The risk stack remains heavy: prior-year loss of Rs. 6,973.6 lakhs, direct tax litigations of Rs. 1,080.3 lakhs, and questionable recoverability of deferred tax assets (Rs. 883.2 lakhs) and indirect tax credits (Rs. 516.4 lakhs), along with unpaid statutory dues.

Forward Outlook

This quarter’s key strategic context is post-divestment repositioning: after exiting Ecron Acunova, management is pursuing diversification outside CRO due to non-compete constraints. The stated forward plan is to close strategic partnerships, mergers, and acquisitions through non-cash transactions in FY2026, but management itself indicates outcomes and financial impact are still uncertain. For the next 2-4 quarters, the main catalysts are concrete closure and execution of these diversification deals rather than organic operating momentum. Current momentum appears decelerated in core operations because business commentary highlights severely impacted operations and no dependable operating revenue base. Until new initiatives convert into recurring revenue and governance overhangs reduce, near-term performance is likely to remain volatile and event-driven.

Strengths

Q3 FY2025-26 reported profit after tax of Rs. 110.96 lakhs and profit before tax of Rs. 110.96 lakhs, reversing from a Rs. 62.78 lakhs loss in the preceding quarter (as per quarterly narrative).
Total expenses were contained at Rs. 35.18 lakhs versus total income of Rs. 146.14 lakhs, indicating a lean current cost structure.
Finance costs were negligible at Rs. 0.06 lakhs, reducing near-term interest burden on the P&L.
Basic and diluted EPS were positive at Rs. 0.08 in Q3 FY2025-26.
The company completed a strategic action in FY2024-25 by divesting 100% of Ecron Acunova Limited, which provides optionality to reposition the business model.

Risks

Auditor opinion is Qualified with explicit going-concern uncertainty, citing severe operational and financial stress factors.
Earnings quality is weak: management commentary says total income of Rs. 146.14 lakhs came entirely from other income, while operations were described as having no operational revenue.
Historical financial damage is significant, with FY2024-25 loss of Rs. 6,973.6 lakhs and substantial net worth erosion noted in risk disclosures.
Tax and compliance overhang is high, including direct tax litigations of Rs. 1,080.3 lakhs and unpaid statutory obligations.
Asset recoverability risk is elevated with deferred tax assets of Rs. 883.2 lakhs and indirect tax credits of Rs. 516.4 lakhs flagged as questionable, while cash-flow and liquidity metrics are largely unavailable in the extract.
2.0
Anthropic Claude Strong Sell
claude-cli (Claude Code)

TAKE Solutions exhibits severe financial distress with zero operational revenue (Rs. 0 lakhs from operations in Q3 FY2025-26) and complete reliance on other income of Rs. 146.14 lakhs to report a nominal profit of Rs. 110.96 lakhs. The company received a qualified audit opinion citing material going concern uncertainties including a massive loss of Rs. 6,973.6 lakhs in FY2024-25, substantial networth erosion, contingent tax liabilities of Rs. 1,080.3 lakhs, and questionable recoverability of deferred tax assets worth Rs. 883.2 lakhs. After divesting its core CRO subsidiary Ecron Acunova Limited in FY2024-25, the company is bound by non-compete obligations that prevent it from operating in its historical industry, leaving it essentially a shell entity with no business model. Management's diversification plans for FY2026 remain entirely speculative with uncertain outcomes, and unpaid statutory dues combined with severely impaired asset values raise serious questions about survival beyond the near term.

Forward Outlook

The company has no operating business following the FY2024-25 divestment of its CRO subsidiary and is constrained by non-compete obligations from re-entering that industry. Management has initiated discussions for diversification into other verticals and potential strategic partnerships, mergers, or acquisitions structured as non-cash transactions, with expectations of positive closure during FY2026, but these remain speculative with no binding commitments or disclosed sectors of interest. The Q3 profit of Rs. 110.96 lakhs was entirely driven by other income rather than operational performance, and with zero revenue from operations, no demonstrated business model, qualified audit opinion on going concern, and over Rs. 2,480 lakhs in disputed tax liabilities with questionable asset recoverability, the company faces existential risk. Investors should expect continued uncertainty and potential inability to sustain operations unless concrete diversification deals materialize and generate sustainable revenue within the next 2-3 quarters.

Strengths

Company reported Q3 FY2025-26 profit after tax of Rs. 110.96 lakhs versus a loss of Rs. 62.78 lakhs in Q2, showing quarterly turnaround albeit driven entirely by non-operating income
Successfully completed divestment of 100% stake in subsidiary Ecron Acunova Limited during FY2024-25, potentially generating proceeds to support operations
Minimal operating expenses of only Rs. 35.18 lakhs in Q3 including employee costs of Rs. 13.53 lakhs and other expenses of Rs. 21.38 lakhs, indicating aggressive cost rationalization
Zero tax expense in Q3 FY2025-26 provides temporary cash preservation, though this reflects lack of taxable operating income rather than tax efficiency

Risks

Zero revenue from operations in Q3 FY2025-26 indicates complete absence of business activity, with total income of Rs. 146.14 lakhs derived entirely from other income sources
Auditors issued qualified opinion citing material going concern uncertainties including Rs. 6,973.6 lakhs loss in FY2024-25, significant networth erosion, and substantial doubt about ability to realize assets and discharge liabilities
Contingent direct tax litigations totaling Rs. 1,080.3 lakhs plus questionable recoverability of deferred tax assets of Rs. 883.2 lakhs and indirect tax credits of Rs. 516.4 lakhs represent potential cash outflows exceeding Rs. 2,480 lakhs
Non-compete obligations in the CRO industry following divestment of Ecron Acunova Limited prevent the company from operating in its core historical business vertical
Unpaid statutory dues and deterioration in asset values as flagged by auditors indicate severe liquidity stress and potential regulatory or legal consequences
Diversification initiatives including strategic partnerships, mergers, and acquisitions remain entirely in discussion stage with management acknowledging uncertain outcomes and unascertainable impact on going concern assumptions

Score History

Score Timeline

Quarterly Report News Event

All Scores

Date Report Score Sentiment AI
Mar 6, 2026 Take Solutions Limited - Financial Results (15/2/2026) 3.5 Sell ChatGPT
Feb 28, 2026 Take Solutions Limited - Financial Results (15/2/2026) 2.0 Strong Sell Claude

Related Stocks on NSE

Precision Wires India Limited
PRECWIRE
7.2
Loyal Textile Mills Limited
LOYALTEX
5.0
MSP Steel & Power Limited
MSPL
5.6
United Drilling Tools Limited
UNIDT
7.4
W S Industries (I) Limited
WSI
3.8
Dhampur Bio Organics Limited
DBOL
5.0
Debock Industries Limited
DIL
3.5
Shankar Lal Rampal Dye-Chem Limited
SRD
5.5

Frequently Asked Questions

What is the AI Stock Score?

The AI Stock Score is a composite rating from 0-10 generated by analyzing quarterly earnings reports using three leading AI models (Google Gemini, Anthropic Claude, and OpenAI ChatGPT). Each AI independently evaluates financial performance, growth prospects, risks, and market positioning to provide an objective investment perspective.

How should I interpret Buy/Hold/Sell ratings?

Buy (7.0-10.0): Strong fundamentals and positive outlook. Hold (4.0-6.9): Mixed signals, suitable for existing positions. Sell (0-3.9): Deteriorating fundamentals or significant risks. These are AI-generated opinions for informational purposes only, not investment advice.

How is the composite score calculated?

The composite score is the mathematical average of the latest scores from each AI provider. For example, if Gemini rates 7.5, Claude rates 4.5, and ChatGPT rates 6.0, the composite score would be (7.5+4.5+6.0)/3 = 6.0. This multi-AI approach reduces bias from any single model.

How often are scores updated?

Scores are automatically generated within hours of quarterly earnings results being published on NSE. The system monitors earnings announcements 4 times daily and processes new reports immediately. Check the "Last Updated" date at the top of this page for the most recent analysis timestamp.

Is this financial advice?

No. This is AI-generated analysis for informational and educational purposes only. MarketsHost is not a SEBI-registered Research Analyst or Investment Adviser. AI models can produce inaccurate results. Always consult a qualified financial advisor and conduct your own due diligence before making investment decisions.